From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Emergency Medicine>
  4. Summary and Comment

Aminotransferase Elevation in Healthy Adults Taking Acetaminophen

The clinical significance of the elevations is unclear.

Acetaminophen has a well-established safety record, and chronic treatment with 4 g per day has been confirmed to be safe. However, a recent trial found that a novel hydrocodone/acetaminophen combination was associated with a high incidence of serum alanine aminotransferase (ALT) elevations. To characterize the association between ALT levels and acetaminophen, researchers conducted a randomized, single-blind (participants), controlled, pharmaceutical–company-sponsored trial in 145 healthy adult volunteers (78% men; mean age, 34).

Every 6 hours for approximately 1 week, participants received one of five treatments: (1) placebo alone; (2) 1g of acetaminophen alone; and (3–5) 1g acetaminophen with 15 mg oxycodone, 4 mg hydromorphone, or 30 mg morphine, respectively. During the study, participants were housed in two inpatient clinical pharmacology facilities, and their diets were controlled. Treatment was discontinued if ALT concentrations exceeded three times the upper limit of normal (considered clinically significant elevation).

Trough acetaminophen concentrations did not exceed therapeutic limits in any participant. The incidence of clinically significant ALT elevations was 39% in all active-treatment groups combined (range, 31%–44%) versus 0% in the placebo cohort. After treatment discontinuation, ALT levels continued to increase for a median of 2 days and remained significantly elevated for a median of 6.5 days before returning to normal.

Comment: Given the exceptional safety profile of acetaminophen, the authors surmise that the ALT elevations observed in this study would have resolved with continued administration of acetaminophen. They call for longer-duration trials to address this issue. The incidence of ALT elevations found in this study was higher than that reported in other studies. This difference likely reflects the study population’s relatively high proportion of Hispanics (57%), as Hispanics have higher baseline ALT levels than do whites. Pending further investigation, there seems to be nothing here to discourage the routine use of acetaminophen as an analgesic.

— John A. Marx, MD, FAAEM, FACEP

Published in Journal Watch Emergency Medicine August 4, 2006

Citation(s):

Watkins PB et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: A randomized controlled trial. JAMA 2006 Jul 5; 296:87-93.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Other Perspectives

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2006. Massachusetts Medical Society. All rights reserved.